WallStSmart

Zenvia Inc (ZENV)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Zenvia Inc generates 324% more annual revenue ($1.10B vs $258.90M). ZENV leads profitability with a -11.0% profit margin vs -15.5%. ZEPP earns a higher WallStSmart Score of 41/100 (D).

ZENV

Hold

39

out of 100

Grade: F

Growth: 6.7Profit: 2.0Value: 5.0Quality: 5.0
Piotroski: 4/9Altman Z: 0.29

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for ZENV.

ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ZENV3 strengths · Avg: 9.0/10
Price/BookValuation
0.0x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.139/10

Conservative balance sheet, low leverage

Revenue GrowthGrowth
23.6%8/10

Revenue surging 23.6% year-over-year

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

ZENV4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$70.69M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-15.5%2/10

ROE of -15.5% — below average capital efficiency

Free Cash FlowQuality
$-33.04M2/10

Negative free cash flow — burning cash

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : ZENV

The strongest argument for ZENV centers on Price/Book, Debt/Equity, Revenue Growth. Revenue growth of 23.6% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : ZENV

The primary concerns for ZENV are EPS Growth, Market Cap, Return on Equity.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

ZENV profiles as a growth stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ZEPP scores higher overall (41/100 vs 39/100) and 43.0% revenue growth. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Zenvia Inc

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Zenvia Inc (ZENV) is a leading technology company focused on transforming customer engagement through its advanced cloud-based communication platform. By offering a multi-channel solution that integrates SMS, voice, email, and social media, Zenvia enables businesses to enhance customer interactions and drive satisfaction. With a keen focus on digital transformation, the company is well-positioned to capitalize on the growing demand for innovative communication solutions, especially within the dynamic Latin American market. Zenvia's commitment to delivering state-of-the-art customer engagement tools places it at the forefront of the evolving digital communication landscape, making it a compelling prospect for institutional investors.

Visit Website →

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?